Scientists Identify NANOG as a Key Gene Guiding Early Human Embryo Development

2026-06-26 |

Early human development depends on a delicate sequence of genetic signals that guides a single fertilized cell into a complex embryo. A new study has shown that one gene, NANOG, acts as a crucial molecular switch in this process. When it fails, the embryo's developmental program is thrown off course.

Researchers have long known that NANOG is essential for embryo formation in mice, where it helps establish both the early embryo and the supporting yolk sac. Until now, however, its precise role in human development remained uncertain. Ethical restrictions on embryo research have made it difficult to determine whether findings from mice truly apply to humans.

Human Embryos Under the Microscope

An international team led by developmental biologist Kathy Niakan of the University of Cambridge set out to investigate the function of NANOG directly in human embryos. The researchers used developmentally normal embryos donated after in vitro fertilization (IVF) treatment with informed consent. The research was strictly limited to 14 days of development, in accordance with widely accepted ethical guidelines.

Previous embryo gene-editing studies often relied on tripronuclear embryos, which have abnormal chromosomal content and cannot develop normally. Although these models are valuable for research, they are imperfect for understanding typical human development. In contrast, the present study focused on embryos that more closely resemble those involved in normal early pregnancies.

To further investigate the role of NANOG, the researchers also studied human embryonic stem cells, which are derived from early embryos and retain the capacity to develop into many different tissue types. Comparing genetically edited embryos with embryonic stem cells allowed the team to examine how disrupting a single gene influences developmental fate.

A Precise Base-Editing Strategy

Rather than using conventional CRISPR/Cas9 gene editing, which cuts both strands of DNA, Niakan's team employed base editing. This newer approach changes individual DNA bases without creating double-strand breaks, reducing the risk of large unintended mutations. It provides a more precise method for inactivating specific genes.

By altering a single DNA base within the NANOG gene, the researchers effectively prevented production of the NANOG protein. Genetic analyses confirmed that off-target effects were minimal. This high level of precision was essential for confidently attributing the observed developmental changes specifically to the loss of NANOG.

NANOG functions as a transcription factor, regulating which genes are activated or silenced during critical stages of development. In early embryos, it plays a central role in maintaining pluripotency, the state in which cells retain the ability to develop into nearly any tissue type. When NANOG was disabled, this regulatory network collapsed.

Embryos Diverted from Building a Fetus

Without functional NANOG, pluripotent epiblast cells were unable to develop into the normal stem cells that give rise to fetal tissues. Instead, they were redirected toward lineages associated with the yolk sac and placenta. In effect, the embryos diverted developmental resources toward supporting structures rather than the future fetus.

As a result, the embryos lacked the appropriate pool of cells needed to generate organs and body structures. Although supporting tissues continued to develop, the core developmental program failed to proceed normally. In practical terms, such embryos would not be expected to develop into viable pregnancies.

Interestingly, the study also revealed an important difference between humans and mice. In humans, NANOG is not required for yolk sac formation itself, despite its crucial role in determining whether cells adopt yolk sac or fetal developmental pathways. This finding highlights important species-specific differences in early embryonic development and demonstrates that human development does not always mirror commonly used animal models.

Implications and Ethical Boundaries

Experts believe the findings substantially advance our understanding of early human embryonic development. Stem cell scientist Dusko Ilic of King's College London, who was not involved in the study, emphasized that the primary value of the research lies in its mechanistic insights. It improves our understanding of how early cell-fate decisions are regulated rather than offering immediate clinical applications.

Ilic also cautioned that these findings should not be interpreted as evidence that embryo editing is safe for reproductive purposes. Significant technical and ethical challenges remain before correcting disease-causing genes in embryos could ever become a clinical reality. Current international guidelines continue to restrict such interventions to carefully regulated research settings.

Developmental biologist Robin Lovell-Badge of the Francis Crick Institute noted that a better understanding of the earliest stages of human development could eventually contribute to reducing infertility, implantation failure, and certain forms of pregnancy loss. However, translating these discoveries into clinical diagnostics or therapies will require extensive additional research and careful regulatory oversight.

The study also demonstrates the value of base editing as a powerful research tool for investigating human embryonic development. Because this technology can disrupt genes with fewer unintended changes than conventional CRISPR systems, it may become increasingly useful for identifying other key genetic regulators during the earliest days after fertilization while remaining within current ethical frameworks.

The findings, published in the journal Nature, add another important piece to the growing understanding of how a precisely coordinated genetic program transforms a small cluster of cells into a developing human embryo. They also reinforce the conclusion that, although animal models remain invaluable, findings from mice cannot always substitute for carefully conducted studies using human tissues and embryos.